Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Guatemala

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Guatemala Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20068
20071
20085
20093
20103
20112
20123
20141
20171
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda11
Hoffmann-La Roche5
Janssen Research & Development, LLC3
Sanofi3
Boehringer Ingelheim2
Novartis Pharmaceuticals2
Lexicon Pharmaceuticals1
Merck Sharp & Dohme LLC1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 229
Diabetes Mellitus9
Glucose Metabolism Disorders8
Dyslipidemias7
Hyperglycemia3
Glucose Intolerance2
Renal Insufficiency, Chronic2
Acute Coronary Syndrome1
Cardiovascular Diseases1
Diabetes Mellitus, Lipoatrophic1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.